MCIM
VNDA icon

Meadow Creek Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Meadow Creek Investment Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$154K Buy
11,594
+544
+5% +$7.58K ﹤0.01% 1102
2019
Q2 		$156K Buy
11,050
+306
+3% +$4.87K ﹤0.01% 1105
2019
Q1 		$198K Hold
10,744
– – ﹤0.01% 1020
2018
Q4 		$281K Buy
+10,744
New +$253K 0.01% 832

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Meadow Creek Investment Management's VNDA Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Vanda Pharmaceuticals (VNDA) stake by 4.9% in Q3 2019, buying an estimated $7.58K and bringing the position to 11,594 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Meadow Creek Investment Management first reported a position in VNDA in Q4 2018 and has held it in 4 quarters since. The position peaked at $281K in Q4 2018. 168 funds tracked by Wall St. Rank hold VNDA as of Q3 2019.

  • Meadow Creek Investment Management held 11,594 shares of Vanda Pharmaceuticals worth $154K as of Q3 2019.
  • Meadow Creek Investment Management bought 544 Vanda Pharmaceuticals shares in Q3 2019, an estimated $7.58K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1102 holding.
  • Meadow Creek Investment Management first reported a position in Vanda Pharmaceuticals in Q4 2018 and has held it in 4 quarters since.
  • Meadow Creek Investment Management's Vanda Pharmaceuticals position peaked at $281K in Q4 2018.
  • 168 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.